Abstract
Purpose
This study was done to propose a study protocol for patients with rheumatoid arthritis (RA) treated with biological agents, by evaluating the contribution of contrast-enhanced magnetic resonance (CE-MR) imaging, a software programme that calculates the volume of synovitis on CE-MR images, and contrast-enhanced ultrasound (CEUS).
Materials and methods
Sixteen patients with RA receiving treatment with biologics were analysed. The patients underwent clinical examination, CE-MR imaging and CEUS on the same day. Images were postprocessed with the software and evaluated independently by three physicians in terms of RAMRIS (Rheumatoid Arthritis Magnetic Resonance Imaging Score), SAMIS (Simplified Rheumatoid Arthritis Magnetic Resonance Imaging Score) and CEUS grade. The techniques were correlated statistically.
Results
The RAMRIS and SAMIS scores were found to correlate statistically. CE-MR imaging correlated with the clinical data (p < 0.05), whereas CEUS did not. The data provided by the software did not correlate statistically with the other techniques. The most painful joint was consistently found to be the joint with most synovitis.
Conclusions
CE-MR imaging may be used prior to treatment and for long-term follow-up. CEUS might be useful in the short-term follow-up, as it seems to provide an indication of the presence or absence of disease, though not of its severity. The software is a very useful tool that can supplement, but not replace, the other techniques.
Similar content being viewed by others
References
Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4(3):130–136
Backhaus M, Kamradt T, Sandrock D et al (1999) Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 42:1232–1245
Firestein GS (1999) Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest 103:3–4
Stronger CM, Steak DG, Junky A et al (1999) Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest 103:47–54
Van Tuyl LH, Lems WF, Voskuyl AE et al (2008) Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90 % remission in a pilot trial. Ann Rheum Dis 67:1574–1577
Klauser A, Demharter J, De Marchi A et al (2005) The IACUS study group. Contrast-enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Euro Radiol 15:2404–2410
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Wakefield RJ, Brown AK, O’Connor PJ et al (2003) Power Doppler sonography: improving disease activity assessment in inflammatory musculoskeletal disease. Arthritis Rheum 48:285–288
Stone M, Bergin D, Whelan B et al (2001) Power Doppler ultrasound assessment of rheumatoid hand synovitis. J Rheumatol 28:1979–1982
Schmidt WA, Volker L, Zacher J et al (2000) Colour Doppler ultrasonography to detect pannus in knee joint synovitis. Clin Exp Rheumatol 18:439–444
Hirohata S, Sakakibara J (1999) Angioneogenesis as a possible elusive trigger factor in rheumatoid arthritis. Lancet 353:1331
Hermann KG, Backhaus M, Schneider U et al (2003) Rheumatoid arthritis of the shoulder joint: comparison of conventional radiography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging. Arthritis Rheum 48:3338–3349
Fiocco U, Ferro F, Cozzi L et al (2003) Contrast medium in power Doppler ultrasound for assessment of synovial vascularity: comparison with arthroscopy. J Rheumatol 30:2170–2176
Suter LG, Fraenkel L, Braithwaite RS (2011) Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management. Arch Intern Med 171:657–667
Suter LG, Fraenkel L, Braithwaite RS (2011) Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) 63:675–688
McQueen F, Lassere M, Edmonds J et al (2003) OMERACT rheumatoid arthritis magnetic resonance imaging studies. Summary of OMERACT 6 MR imaging module. Rheumatol 30:1387–1392
Cyteval C, Miquel A, Hoa D (2010) Rheumatoid arthritis of the hand: monitoring with a simplified MR imaging scoring method—preliminary assessment. Radiology 256:863–869
Østergaard M, Peterfy C, Conaghan P et al (2003) OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies: core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 30:1385–1386
Scott DL, Laasonen L, Priolo F et al (1997) The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol 15:S53–S61
Stramare R, Raffeiner B, Ciprian L et al (2012) Evaluation of finger joint synovial vascularity in patients with rheumatoid arthritis using contrast-enhanced ultrasound with water immersion and a stabilized probe. J Clin Ultrasound 40:147–154
Leech SJ, Gukhool J, Blaivas M (2003) ED ultrasound evaluation of the index flexor tendon: a comparison of water bath evaluation technique (WET) versus direct contact ultrasound. Acad Emerg Med 10:573
Van der Heide A, Jacobs JW, Bijlsma JW et al (1996) The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 124:699–707
Nell VP, Machold KP, Eberl G et al (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43:906–914
Aletaha D, Funovits J, Keystone EC, Smolen JS (2007) Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 56:3226–3235
Möttönen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single drug therapy in early rheumatoid arthritis: a randomized trial—FIN-RACo trial group. Lancet 353:1568–1573
Narváez JA, Narváez J, De Lama E, De Albert M (2010) MR imaging of early rheumatoid arthritis. Radiographic 30:143–163
Ostergaard M, Hansen M, Stoltenberg M et al (1999) Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 42:918
Zeman MN, Scott PJ (2012) Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging 2:174–220
Sommer OJ, Kladosek A, Weiler V et al (2005) Rheumatoid arthritis: a practical guide to state-of-the-art imaging, image interpretation, and clinical implications. Radiographics 25:381–398
Freeston JE, Bird P, Conaghan PG (2009) The role of MRI in rheumatoid arthritis: research and clinical issues. Curr Opin Rheumatol 21:95–101
Lee SH, Suh J-S, Shin MJ et al (2008) Quantitative assessment of synovial vascularity using contrast-enhanced Power Doppler ultrasonography: correlation with histologic findings and MR imaging findings in arthritic rabbit knee model. Korean J Radiol 9:45–52
Conflict of interest
Roberto Stramare, Alessandro Coran, Alex Faccinetto, Giulia Costantini, Livio Bernardi, Costantino Botsios, Egle Perissinotto, Enrico Grisan, Valeria Beltrame and Bernd Raffeiner declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stramare, R., Coran, A., Faccinetto, A. et al. MR and CEUS monitoring of patients with severe rheumatoid arthritis treated with biological agents: a preliminary study. Radiol med 119, 422–431 (2014). https://doi.org/10.1007/s11547-013-0369-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-013-0369-5